LHDX

15-12G - Lucira Health, Inc. (0001652724) (Filer)

8-K - Lucira Health, Inc. (0001652724) (Filer)

NT 10-Q - Lucira Health, Inc. (0001652724) (Filer)

S-8 POS - Lucira Health, Inc. (0001652724) (Filer)

S-8 POS - Lucira Health, Inc. (0001652724) (Filer)

8-K - Lucira Health, Inc. (0001652724) (Filer)

NT 10-Q - Lucira Health, Inc. (0001652724) (Filer)

8-K - Lucira Health, Inc. (0001652724) (Filer)

8-K - Lucira Health, Inc. (0001652724) (Filer)

NT 10-K - Lucira Health, Inc. (0001652724) (Filer)

25-NSE - Lucira Health, Inc. (0001652724) (Subject)

8-K - Lucira Health, Inc. (0001652724) (Filer)

8-K - Lucira Health, Inc. (0001652724) (Filer)

4 - Lucira Health, Inc. (0001652724) (Issuer)

4 - Lucira Health, Inc. (0001652724) (Issuer)

4 - Lucira Health, Inc. (0001652724) (Issuer)

4 - Lucira Health, Inc. (0001652724) (Issuer)

The FDA provided additional information about the agency's interactions and decisions regarding the emergency use authorization (EUA) of Lucira Health Inc's (OTC: LHDXQ) COVID-19 & Flu Home test. The statement comes due to concerns about the agency's length and timing of the EUA clearance and its bankruptcy filing, which said the delay in EUA financially hit the company. In an investor report, Lucira blamed the FDA's "protracted" authorization process for its combination Covid and flu at-home test.  Lucira applied to the FDA for authorization of its novel test last May and expected to receive a thumbs-up by the end of summer before the flu season started. Canada authorized Lucira's test

Failures of Covid vaccine maker Novavax Inc (NASDAQ:NVAX) and diagnostic start-up Lucira Health Inc (NASDAQ:LHDX) show that companies often succeed or fail, owing to the whims of the government.  Last week, while reporting Q4 earnings, Novavax raised doubts about its ability to remain in business and announced plans to cut spending.  The Covid-19 vaccine was Novavax's first and only commercial product in its 36-year history, Wall Street Journal writes. However, the product flopped after successful trials thanks to regulatory delays and manufacturing hiccups. Operation Warp Speed awarded Novavax $1.6 billion to cover testing and manufacturing costs of its experimental vaccine in exchange f

Gainers ObsEva SA (NASDAQ:OBSV) surged 86.6% to $0.1978 after dropping over 12% on Thursday. ObsEva recently announced strategic reorganization to consolidate operations in Switzerland. Altamira Therapeutics Ltd. (NASDAQ:CYTO) shares jumped 52.7% to $3.59 after the company said data from a recent peer-reviewed clinical study demonstrated Bentrio's superior nasal residence time and rheological properties. Lavoro Limited (NASDAQ:LVRO) gained 44.7% to $13.86. Lavoro and TPB Acquisition Corporation I announced completion of business combination. HUB Cyber Security (Israel) Ltd. (NASDAQ:HUBC) rose 36.6% to $1.71 after dipping 21% on Thursday. Seer, Inc. (NASDAQ:SEER) gained 35% to $5.68 a

Gainers Seer (NASDAQ:SEER) shares moved upwards by 39.4% to $5.87 during Friday's regular session. As of 12:30 EST, Seer's stock is trading at a volume of 1.6 million, which is 437.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $367.7 million. The company's, Q4 earnings came out yesterday. Bullfrog AI Hldgs (NASDAQ:BFRG) shares rose 39.18% to $3.8. As of 12:30 EST, Bullfrog AI Hldgs's stock is trading at a volume of 4.2 million, which is 1055.1% of its average full-day volume over the last 100 days. The company's market cap stands at $21.4 million. Ardelyx (NASDAQ:ARDX) stock rose 36.18% to $3.94. Trading volume for Ardelyx's s

Gainers Bullfrog AI Hldgs (NASDAQ:BFRG) stock increased by 47.6% to $4.03 during Friday's pre-market session. The company's market cap stands at $22.7 million. Rubius Therapeutics (NASDAQ:RUBY) shares moved upwards by 31.71% to $0.15. The company's market cap stands at $13.5 million. Ardelyx (NASDAQ:ARDX) shares rose 17.3% to $3.39. The market value of their outstanding shares is at $673.1 million. The company's, Q4 earnings came out yesterday. Akari Therapeutics (NASDAQ:AKTX) shares rose 16.24% to $0.38. The market value of their outstanding shares is at $28.2 million. Milestone Scientific (AMEX:MLSS) shares rose 13.92% to $0.9. The company's market cap stands at $62.8 million. Confor

Gainers Exela Technologies, Inc. (NASDAQ:XELA) shares surged 45% to $0.0701 after the company announced $51 million of new funding, amendment increases existing securitization facility to $185 million and other related transactions. BioRestorative Therapies, Inc. (NASDAQ:BRTX) shares jumped 34.7% to $3.76 after the company announced the United States Patent and Trademark Office has issued a notice of allowance for a patent application related to the Company's metabolic ThermoStem program. Diversified Healthcare Trust (NASDAQ:DHC) surged 30% to $1.21 after the company posted a profit for the fourth quarter. Desktop Metal, Inc. (NYSE:DM) gained 23% to $1.8550 after the company reported

Gainers BioRestorative Therapies (NASDAQ:BRTX) stock rose 32.4% to $3.69 during Thursday's regular session. BioRestorative Therapies's stock is trading at a volume of 28.4 million shares as of 12:30 EST. This is 189085.2% of its average full-day volume over the last 100 days. The company's market cap stands at $13.5 million. OncoSec Medical (NASDAQ:ONCS) shares rose 19.6% to $2.44. The current volume of 31.8 million shares is 2304.3% of OncoSec Medical's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $7.2 million. Biophytis (NASDAQ:BPTS) stock moved upwards by 19.56% to $0.5. The current volume of 7.6 million shares is 1275.2

Gainers Biophytis (NASDAQ:BPTS) stock moved upwards by 34.1% to $0.56 during Thursday's pre-market session. The company's market cap stands at $11.4 million. OncoSec Medical (NASDAQ:ONCS) shares rose 32.35% to $2.7. The market value of their outstanding shares is at $8.0 million. Avenue Therapeutics (NASDAQ:ATXI) stock increased by 30.35% to $1.46. The market value of their outstanding shares is at $8.0 million. BioRestorative Therapies (NASDAQ:BRTX) shares increased by 26.52% to $3.53. The company's market cap stands at $12.9 million. Apexigen (NASDAQ:APGN) shares rose 10.46% to $0.95. The company's market cap stands at $23.4 million. Chimerix (NASDAQ:CMRX) shares increased by 9.96% t